ASTH - Astrana Health Inc.

Astrana Health operates a physician-centric, value-based care network built around its Accountable Care Organization (ACO) and Independent Physician Association (IPA) platform, connecting primary care and specialty physicians to manage patient health outcomes under risk-sharing contracts. The core business model is B2B2C: Astrana contracts with health plans (Medicare, Medicaid, commercial) to take on capitated risk for patient populations, then coordinates care delivery through its affiliated physician network. Revenue is approximately $2.2B annually, concentrated in California with recent expansion into Texas and other Western U.S. markets. The company generates revenue primarily through capitated payments per member per month rather than fee-for-service, meaning it profits by keeping patients healthy and reducing unnecessary utilization.

Past Year Trends

• Astrana Health closed the $708M Prospect Health acquisition on July 1, 2025, adding 600,000 members and 11,000+ providers across California, Texas, Arizona, and Rhode Island, pushing Q1 2026 revenue to $965.1M (53% YoY growth) and EPS to $0.74 vs. the $0.29 consensus estimate. (Bullish)
• FY2025 gross margin compressed to 10.25% from 13.3% in FY2024, and Adjusted EBITDA margin fell to 6% from 8%, driven by $1.04B in long-term debt interest expense accumulated through two large acquisitions in twelve months plus elevated integration costs. (Bearish)
• Astrana disclosed a material weakness in internal controls over financial reporting related to acquisition and purchase accounting processes following the rapid integration of Collaborative Health Systems (closed October 2024) and Prospect Health (closed July 2025). (Bearish)

Next Year Trends

• Prospect Health integration is expected to yield $12-15M in synergies over 12-18 months from the July 2025 close, and management has issued 2026 Adjusted EBITDA guidance of $250-280M vs. the compressed FY2025 run-rate, with the shift to a delegated full-risk single-payer model as the primary margin recovery lever. (Bullish)
• California Medicaid policy changes affecting undocumented populations are expected to reduce Astrana's Medicaid membership by 10-15% per 2026 guidance, with downside risk of 20-25% cuts over the next 24 months that would pressure the Care Partners segment's largest state concentration. (Bearish)
• The 2027 CMS Medicare Advantage rate notice set a 2.48% benchmark increase translating to an effective approximately 4.98% rate improvement for Astrana given its MA risk factor just above 1.0, providing a direct tailwind to per-member revenue in its largest payer line for the upcoming contract year. (Bullish)

Red Flags

No severe red flags identified as of August 2025.